Stablepoint Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.53M | Buy |
21,938
+113
| +0.5% | +$7.9K | 0.26% | 112 |
|
|
2025
Q1 | $1.6M | Buy |
21,825
+832
| +4% | +$61.2K | 0.29% | 102 |
|
|
2024
Q4 | $1.38M | Sell |
20,993
-939
| -4% | -$61.5K | 0.25% | 119 |
|
|
2024
Q3 | $1.71M | Buy |
21,932
+174
| +0.8% | +$13.6K | 0.31% | 93 |
|
|
2024
Q2 | $1.7M | Sell |
21,758
-1,245
| -5% | -$97.6K | 0.33% | 91 |
|
|
2024
Q1 | $1.56M | Buy |
23,003
+5,695
| +33% | +$386K | 0.32% | 99 |
|
|
2023
Q4 | $1.17M | Buy |
+17,308
| New | +$1.17M | 0.3% | 93 |
|